ENTEROME SA, a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to de-code molecular interactions in the gut microbiome impacting human health, today announces that it has received Investigational New Drug […]
4D pharma plc (AIM: DDDD) (“4D” or the “Company”), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, is pleased to announce that its […]
Sandwalk BioVentures, the strategy firm specialized on microbiome technologies, has announced its collaboration with General Inception, a US-based venture studio focused on co-founding and building science-based companies from concept on. Sandwalk will lead the Microbiome […]
In a study recently published in Nature Communications, scientists from The Novo Nordisk Foundation Center for Biosustainability (DTU) and Yale University have investigated how bacteria that are commonly found in sugarcane ethanol fermentation affect the […]
The Centre for Disease Control and Prevention (CDC) has declared insufficient sleep a ‘public health problem’, with more than one-third of American adults not getting enough sleep on a regular basis. Experts in gut microbiome […]
Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to advancing therapies that address the global rise of multi-drug resistant infections, announced today that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug […]
Novozymes, the world leader in biological solutions, announced the acquisition of the microbiome R&D team and data science platform of Biota. Based in San Diego, US, Biota pioneered industrial genomics using microbiome insights, impacting the […]
You must be logged in to view this content. Please login here or if you do not have an account register here.
The human gut consists of a complex community of microbes that consume and secrete hundreds of small molecules–a phenomenon called cross-feeding. However, it is challenging to study these processes experimentally. A new study, published in […]
Ferring Pharmaceuticals, Rebiotix Inc., a Ferring Company, and MyBiotics Pharma Ltd. today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women of reproductive age […]
Scientists from Nanjing University and the University of Macau have devised a new approach to extend the survival of transplanted probiotics in vivo, enhancing the efficacy of cancer chemo-/immunotherapies in mice. The paper entitled “Smectite […]